WATERTOWN, Mass., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ:KYMR), a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using targeted protein degradation (TPD), today announced that the Company will participate in fireside chats at the following upcoming investor events:
- TD Cowen 44th Annual Healthcare Conference in Boston, MA on March 6 at 12:50 p.m. ET;
- Leerink Partners Global Biopharma Conference in Miami, FL on March 12 at 3:40 p.m. ET;
- Jefferies Biotech on the Bay Summit in Miami, FL on March 13, the Company will host one-on-one meetings ...